Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It looks like the revenues in the 4th quarter were the same as those in the 3rd quarter. I guess the revenue from their new customers hasn't shown up yet? At least they were able to pay off their loans. They are talking about acquisitions and mergers. I wonder where they are going to get the money for that?
AMEH..$0.081.. New 10K in Ibox..
Looks great to me .. Thay had a super 2'nd half..hank
AMEH.. $0.125
10 Bagger, what price do you think it will go to
My opinion as to price I just can not answer.. If momentuim were to get behind AMEH a 10 bagger in a short period of is possible... But if value was the reason that you purchased AMEH,, this stock is a keeper that has the possibility of becoming a retirement check.. Thats a long way from $0.125 but it is still a real possibility.. Speak to management,, they seem convinced that it will fund thier retirement,, and sound as though they believe it.. Yes I drank the Kool-Aid..
AMEH is growing and it's provided services are gaining greater acceptance within the Hospital industry.. I expect AMEH to become profitable this year and I also expect that it's capitolization will not be violated with dilution.. AMEH management has commited themselves to make AMEH work and so far they seem to be doing the right things.. For a stock that trades at this price they have a good balance sheet with out any real debt or other restrictions that may slow growth..
The release below proves how far AMEH has come in the past year and is the best thing that they have put on thier corpoate Resume.. hank
=================================================
Apollo Medical Holdings, Inc. Announces Strategic Partnership with Benchmark Hospitalists to Provide Hospitalist Services at Hollywood Presbyterian Medical Center
Posted: April 2, 2010
GLENDALE, Calif.--(BUSINESS WIRE)--Apollo Medical Holdings, Inc. (OTCBB:AMEH - News), a leading provider of hospitalist services to the healthcare community, today announced that ApolloMed Hospitalists, one of its affiliated medical groups, has entered into a strategic partnership with Benchmark Hospitalists, a division of Emergent Medical Associates, to provide hospitalist services at Hollywood Presbyterian Medical Center, a 434-bed acute care hospital.
“We are excited about the opportunity to work with Benchmark to expand our service offering to Hollywood Presbyterian Medical Center. We look forward to working with Benchmark on this and future collaborative projects,” stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc.
“Our partnership with Apollo allowed us to put in place a comprehensive hospitalist solution for Hollywood Presbyterian Medical Center,” stated Mark Bell, M.D., President of Benchmark Hospitalists. “Benchmark is known for its superior quality, efficiently run programs and we are pleased to be partnering with ApolloMed who shares our tradition of excellence.”
ApolloMed named Kevin Berger, M.D. as the Hospitalist Medical Director for Hollywood Presbyterian Medical Center.
About Apollo Medical Holdings, Inc.
Apollo is a leading provider of hospitalist services to the healthcare community in the Greater Los Angeles area. The company intends to capitalize on the growing market for hospital-based physicians, such as hospitalists, or physicians with expertise in hospital medicine. There are 4900 acute care hospitals in the U.S., with over 35 million annual admissions. Total U.S. spending on hospital care is over $650 billion, and is expected to increase to $1.3 trillion by 2016. There are tremendous inefficiencies in the delivery of inpatient care and a high rate of hospital errors. Both of these are drivers for the growth of hospital-based medicine. Apollo and its affiliated medical groups have proven expertise in providing excellent and efficient care to hospitalized patients.
To learn more about ApolloMed, please visit our website: www.apollomed.net
About Benchmark Hospitalists
Headquartered in Manhattan Beach, CA, Benchmark is a premier provider of hospitalist services in Southern California. Benchmark’s proprietary approach, focus on clinical excellence and patient satisfaction, as well as its deep experience in all aspects of hospital management, combine to allow the creation of unique hospitalist solutions for each client and achieve superior results. Benchmark has a proven track record of improving key performance and satisfaction indicators and demonstrating a significant ROI on its hospitalist programs.
To learn more about Benchmark, please visit our website: www.benchmark.md
Contact:
ApolloMed PR Contact:Kyle Francis818-507-4617orBenchmark PR Contact:Alecia Waisanen424-241-1595awaisanen@benchmark.md
I got in yesterday at .12. Looks pretty good. Does anyone have any idea how much new revenue they get from each new hospital? It seems that they have accelerated the rate of addition of new hospitals. Also seems like they are keeping costs down. 10 Bagger, what price do you think it will go to?
I got in yesterday at .12. Looks pretty good. Does anyone have any idea how much new revenue they get from each new hospital? It seems that they have accelerated the rate of addition of new hospitals. Also seems like they are keeping costs down.
ameh ...hard to buy.
i bid .128 and didn't fill in an hour. so i reduced my bid to .12 and it took another hour to fill. odd trading.
AMEH..$0.111
Added again today..hank
====================================
AMEH Overview...
ApolloMed is a leader in providing hospitals, physician groups and managed care organizations clinical solutions through outsourced hospitalist programs. We are a physician-led group focused on providing, managing, and coordinating the care of hospitalized patients. Over past 10 years we have been able to help our partners improve clinical outcomes, increase patient satisfaction, reduce average length of stay and realize greater efficiencies through the application of best practices and quality management.
ApolloMed currently offers its services at 17 hospitals in the Greater Los Angeles Area. The Company signs exclusive contracts with its partners to staff and manage professional programs for the general care of hospitalized patients. We are able to customize our services to improve patient care and achieve financial and operational benefits for our partners. We tailor each program to meet the needs of our clients and their patients.
To learn more about how ApolloMed can help your organization, please contact us at (818) 396-8050.
What does ApolloMed do?
Founded in June 2001, Apollo Medical Holdings, Inc. (“ApolloMed” or the “Company”) is a leading provider of hospitalist services in the Greater Los Angeles, California area. Hospitalist medicine is organized around the admission and care of patients in an inpatient facility such as a hospital or skilled nursing facility and is focused on providing, managing and coordinating the care of hospitalized patients. ApolloMed employs affiliated hospitalists at over 17 hospitals.
What is ApolloMed’s ticker symbol and on what exchange does it trade?
ApolloMed’s ticker is AMEH.OB. It is traded on the OTC Bulletin Board.
Where is ApolloMed incorporated?
Delaware
Where is ApolloMed headquartered?
ApolloMed is headquartered in Glendale, CA.
When does ApolloMed’s fiscal year end?
ApolloMed’s fiscal year end is January 31.
Who is ApolloMed’s independent auditor?
ApolloMed’s independent auditor is Kabani & Co, Inc. They can be reached at: 6033 West Century Blvd., Suite 810 Los Angeles, CA 90045.
Who are the Company’s officers and directors?
The biographies of ApolloMed’s officers and directors are available in the Management and Board of Directors sections of the AMEH website.
Who is ApolloMed’s transfer agent and how does one contact them regarding stock certificates or change of address?
ApolloMed’s transfer agent is OTC Stock Transfer, Inc. They can be contacted at: 231 East 2100 South Ste F, Salt Lake City, UT 84115 Phone: (801) 485-5555 Fax: (801) 486-0562 Website: www.otcstock.net
What is ApolloMed’s cusip number?
ApolloMed’s cusip number is 03763A108.
AMEH.. $0.1108
Bought additional shares today..(04/06/10 12:08 PM EDT Buy 24888 AMEH Executed @ $0.1108 Details | Edit )... The new contract added much to the AMEH business plan.. Not only does it increase it's reach into another hospital but Hollywood Presbyterian Medical Center, a 434-bed acute care hospital is a great hosipal to have on it's resume.. AMEH has attracted several new hospitals to it's services during the past year.. AMEH has a great balance sheet and has fallen under everones radar .. hank
Press Release Source: Apollo Medical Holdings, Inc. On Friday April 2, 2010, 9:00 am EDT
GLENDALE, Calif.--(BUSINESS WIRE)--Apollo Medical Holdings, Inc. (OTCBB:AMEH - News), a leading provider of hospitalist services to the healthcare community, today announced that ApolloMed Hospitalists, one of its affiliated medical groups, has entered into a strategic partnership with Benchmark Hospitalists, a division of Emergent Medical Associates, to provide hospitalist services at Hollywood Presbyterian Medical Center, a 434-bed acute care hospital.
AMEH.. $0.12 Cross Post..
Posted by: 10 bagger Date: Monday, April 05, 2010 10:57:33 AM
In reply to: 10 bagger who wrote msg# 2796 Post # of 2799
AMEH.. $0.12
TABLE POUNDER.. IT's Thin..............
Apollo Medical Holdings, Inc.
1010 North Central Avenue
Suite 201
Glendale, CA 91202
United States - Map
Phone: 818-245-1114
Fax: 818-245-1115
Web Site: http://www.apollomed.net
DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Specialized Health Services
Full Time Employees: 3
BUSINESS SUMMARY
Apollo Medical Holdings, Inc, together with its subsidiaries, provides management services to medical groups that provide inpatient care services in the United States. The company offers services for hospitals, such as providing care from the emergency room through hospital discharge; admission and care of unassigned and/or uninsured patients; inpatient internal medicine consultation services; emergency room clinical decision unit services; and development of hospital-based physicians programs, including pulmonary, critical care, cardiology, and nephrology. Its services for hospitals also include in-hospital inpatient coverage services; development of evidence-based medicine protocols for common diagnoses; implementation of patient safety guidelines; education of nurses and hospital staff; analysis of statistics via the ApolloWeb, a practice management software program, which allows a physician to enter patient information in real-time; and care of patients at academic medical centers, including the education of medical students, interns, and residents. The company also offers services for health carriers and medical groups, which comprise admission and care of assigned patients; communication with primary care physicians upon admission, during the patient?s hospital stay, and upon discharge; transfer of out-of-network patients back to designated hospitals; and communication with case managers, social workers, and medical group personnel, as well as hospital-based physician consulting services. Apollo Medical Holdings, Inc is headquartered in Glendale, California.
-----------------------------------------------------------
Apollo Medical Holdings, Inc. Announces Strategic Partnership with Benchmark Hospitalists to Provide Hospitalist Services at Hollywood Presbyterian Medical Center............
Press Release Source: Apollo Medical Holdings, Inc. On Friday April 2, 2010, 9:00 am EDT
GLENDALE, Calif.--(BUSINESS WIRE)--Apollo Medical Holdings, Inc. (OTCBB:AMEH - News), a leading provider of hospitalist services to the healthcare community, today announced that ApolloMed Hospitalists, one of its affiliated medical groups, has entered into a strategic partnership with Benchmark Hospitalists, a division of Emergent Medical Associates, to provide hospitalist services at Hollywood Presbyterian Medical Center, a 434-bed acute care hospital.
“We are excited about the opportunity to work with Benchmark to expand our service offering to Hollywood Presbyterian Medical Center. We look forward to working with Benchmark on this and future collaborative projects,” stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc.
“Our partnership with Apollo allowed us to put in place a comprehensive hospitalist solution for Hollywood Presbyterian Medical Center,” stated Mark Bell, M.D., President of Benchmark Hospitalists. “Benchmark is known for its superior quality, efficiently run programs and we are pleased to be partnering with ApolloMed who shares our tradition of excellence.”
ApolloMed named Kevin Berger, M.D. as the Hospitalist Medical Director for Hollywood Presbyterian Medical Center.
About Apollo Medical Holdings, Inc.
Apollo is a leading provider of hospitalist services to the healthcare community in the Greater Los Angeles area. The company intends to capitalize on the growing market for hospital-based physicians, such as hospitalists, or physicians with expertise in hospital medicine. There are 4900 acute care hospitals in the U.S., with over 35 million annual admissions. Total U.S. spending on hospital care is over $650 billion, and is expected to increase to $1.3 trillion by 2016. There are tremendous inefficiencies in the delivery of inpatient care and a high rate of hospital errors. Both of these are drivers for the growth of hospital-based medicine. Apollo and its affiliated medical groups have proven expertise in providing excellent and efficient care to hospitalized patients.
To learn more about ApolloMed, please visit our website: http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.apollomed.net&esheet=6236630&lan=en_US&anchor=www.apollomed.net&index=1&md5=6be7ef799b27018e1fb733dd488f1f67
About Benchmark Hospitalists
Headquartered in Manhattan Beach, CA, Benchmark is a premier provider of hospitalist services in Southern California. Benchmark’s proprietary approach, focus on clinical excellence and patient satisfaction, as well as its deep experience in all aspects of hospital management, combine to allow the creation of unique hospitalist solutions for each client and achieve superior results. Benchmark has a proven track record of improving key performance and satisfaction indicators and demonstrating a significant ROI on its hospitalist programs.
To learn more about Benchmark, please visit our website: http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.benchmark.md&esheet=6236630&lan=en_US&anchor=www.benchmark.md&index=2&md5=eebf8c3f5b1fd261155226f8ba919de9
AMEH.. $0.0988..
Apollo Medical Holdings, Inc.
1010 North Central Avenue
Suite 201
Glendale, CA 91202
United States - Map
Phone: 818-245-1114
Fax: 818-245-1115
Web Site: http://www.apollomed.net
DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Specialized Health Services
Full Time Employees: 3
BUSINESS SUMMARY
Apollo Medical Holdings, Inc, together with its subsidiaries, provides management services to medical groups that provide inpatient care services in the United States. The company offers services for hospitals, such as providing care from the emergency room through hospital discharge; admission and care of unassigned and/or uninsured patients; inpatient internal medicine consultation services; emergency room clinical decision unit services; and development of hospital-based physicians programs, including pulmonary, critical care, cardiology, and nephrology. Its services for hospitals also include in-hospital inpatient coverage services; development of evidence-based medicine protocols for common diagnoses; implementation of patient safety guidelines; education of nurses and hospital staff; analysis of statistics via the ApolloWeb, a practice management software program, which allows a physician to enter patient information in real-time; and care of patients at academic medical centers, including the education of medical students, interns, and residents. The company also offers services for health carriers and medical groups, which comprise admission and care of assigned patients; communication with primary care physicians upon admission, during the patient?s hospital stay, and upon discharge; transfer of out-of-network patients back to designated hospitals; and communication with case managers, social workers, and medical group personnel, as well as hospital-based physician consulting services. Apollo Medical Holdings, Inc is headquartered in Glendale, California.
AMEH $0.0988
Apollo Medical Holdings, Inc. Announces Strategic Partnership with Benchmark Hospitalists to Provide Hospitalist Services at Hollywood Presbyterian Medical Center
BUSINESS WIRE)--Apollo Medical Holdings, Inc. (OTCBB:AMEH - News), a leading provider of hospitalist services to the healthcare community, today announced that ApolloMed Hospitalists, one of its affiliated medical groups, has entered into a strategic partnership with Benchmark Hospitalists, a division of Emergent Medical Associates, to provide hospitalist services at Hollywood Presbyterian Medical Center, a 434-bed acute care hospital.
“We are excited about the opportunity to work with Benchmark to expand our service offering to Hollywood Presbyterian Medical Center. We look forward to working with Benchmark on this and future collaborative projects,” stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc.
“Our partnership with Apollo allowed us to put in place a comprehensive hospitalist solution for Hollywood Presbyterian Medical Center,” stated Mark Bell, M.D., President of Benchmark Hospitalists. “Benchmark is known for its superior quality, efficiently run programs and we are pleased to be partnering with ApolloMed who shares our tradition of excellence.”
ApolloMed named Kevin Berger, M.D. as the Hospitalist Medical Director for Hollywood Presbyterian Medical Center.
About Apollo Medical Holdings, Inc.
Apollo is a leading provider of hospitalist services to the healthcare community in the Greater Los Angeles area. The company intends to capitalize on the growing market for hospital-based physicians, such as hospitalists, or physicians with expertise in hospital medicine. There are 4900 acute care hospitals in the U.S., with over 35 million annual admissions. Total U.S. spending on hospital care is over $650 billion, and is expected to increase to $1.3 trillion by 2016. There are tremendous inefficiencies in the delivery of inpatient care and a high rate of hospital errors. Both of these are drivers for the growth of hospital-based medicine. Apollo and its affiliated medical groups have proven expertise in providing excellent and efficient care to hospitalized patients.
To learn more about ApolloMed, please visit our website: http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.apollomed.net&esheet=6236630&lan=en_US&anchor=www.apollomed.net&index=1&md5=6be7ef799b27018e1fb733dd488f1f67
About Benchmark Hospitalists
Headquartered in Manhattan Beach, CA, Benchmark is a premier provider of hospitalist services in Southern California. Benchmark’s proprietary approach, focus on clinical excellence and patient satisfaction, as well as its deep experience in all aspects of hospital management, combine to allow the creation of unique hospitalist solutions for each client and achieve superior results. Benchmark has a proven track record of improving key performance and satisfaction indicators and demonstrating a significant ROI on its hospitalist programs.
To learn more about Benchmark, please visit our website: http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.benchmark.md&esheet=6236630&lan=en_US&anchor=www.benchmark.md&index=2&md5=eebf8c3f5b1fd261155226f8ba919de9
AMEH.. $0.0988
Form 8-K for APOLLO MEDICAL HOLDINGS, INC.
--------------------------------------------------------------------------------
9-Mar-2010
Change in Directors or Principal Officers, Submission of Matters to
ITEM 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.
Adoption of 2010 Equity Incentive Plan
On March 4, 2010, the Board of Directors of Apollo Medical Holdings, Inc. and three members of our Board that own, in the aggregate, approximately 70% of the outstanding shares of our common stock, approved the adoption of the Apollo Medical Holdings Inc., 2010 Equity Incentive Plan, which we refer to as the "2010 Plan."
The 2010 Plan authorizes the granting of the following types of awards to persons who are employees, officers, consultants, advisors, or directors of our company or any of its affiliates:
? Incentive stock options that are intended to satisfy the requirements of
Section 422 of the Internal Revenue Code of 1986, as amended, and the regulations thereunder;
? Non-qualified stock options that are not intended to be incentive stock options;
? Shares of common stock that are subject to specified restrictions, or "restricted stock"; and
? Stock appreciation rights.
Subject to the adjustment provisions of the 2010 Plan that are applicable in the event of a stock dividend, stock split, reverse stock split or similar transaction, up to 5,000,000 shares of common stock may be issued under the 2010 Plan. Our Board of Directors will serve as "Administrator" of the 2010 Plan, except to the extent our Board of Directors delegates the administration of the 2010 Plan to a committee of one or more members of our Board of Directors. The 2010 Plan will expire on March 4, 2020, unless terminated earlier by our Board of Directors. As of the date hereof, no awards have been granted under the 2010 Plan.
The preceding discussion is a summary only of some of the provisions of the 2010 Plan, a complete copy of which is filed as Exhibit 99.1 to this Current Report on Form 8-K.
ITEM 5.07 Submission of Matters to a Vote of Security Holders.
As discussed under Item 5.02, above, on March 4, 2010, the holders of approximately 70% of the outstanding shares of our common stock approved the adoption of the 2010 Plan by written consent without a meeting. The Company intends to file an Information Statement with the Securities and Exchange Commission in accordance with Rule 14c-2 of the Securities Exchange Act of 1934 as soon as practicable relating to this action by written consent. In accordance with Rule 14c-2, the action will become effective 21 calendar days (or 41 calendar days if we pursue the "Notice Only" option pursuant to Rule 14a-16) after an Information Statement is sent to our stockholders of record as of March 4, 2010.
--------------------------------------------------------------------------------
ITEM 9.01 Financial Statements and Exhibits.
(c) Exhibits.
Exhibit Number Document Description
99.1 Apollo Medical Holdings, Inc. 2010 Equity Incentive Plan
AMEH..$0.11
Apollo Medical Holdings, Inc. Announces New Contract and Expansion of Hospitalist Services At Two Hospitals In the Greater Covina Area...
Apollo Medical Holdings, Inc. On Monday November 2, 2009, 9:00 am EST
GLENDALE, Calif.--(BUSINESS WIRE)--Apollo Medical Holdings, Inc. (OTCBB:AMEH - News), a leading provider of management services to medical groups that provide comprehensive hospital-based medical services, today announced that ApolloMed Hospitalists, one of its affiliated medical groups, has signed a hospitalist service agreement with an IPA partner to provide inpatient care at 325-bed CVMC-Queen of the Valley Hospital in West Covina and 222-bed CVMC-InterCommunity Hospital in Covina.
“We are excited about the expansion of our service offering into these two outstanding hospitals. We believe the Greater Covina area represents an excellent growth opportunity for ApolloMed,” stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc.
“ApolloMed now provides hospitalist services at thirteen hospitals in the Greater Los Angeles area,” stated Adrian Vazquez, M.D., President and Chairman of Apollo Medical Holdings, Inc. “Our growth during challenging economic times reinforces the value of the services we offer.”
ApolloMed named Mikhail Blinchik, M.D. as it Site Director for the Greater Covina area.
About Apollo Medical Holdings, Inc.
Apollo is a leading provider of management services to medical groups that provide comprehensive hospital-based medical services. The company intends to capitalize on the growing market for hospital-based physicians, such as hospitalists, or physicians with expertise in hospital medicine. There are 4900 acute care hospitals in the U.S., with over 35 million annual admissions. Total U.S. spending on hospital care is over $650 billion, and is expected to increase to $1.3 trillion by 2016. There are tremendous inefficiencies in the delivery of inpatient care and a high rate of hospital errors. Both of these are drivers for the growth of hospital-based medicine. Apollo and its affiliated medical groups have proven expertise in providing excellent and efficient care to hospitalized patients.
Contact:
Apollo Medical Holdings, Inc.
Warren Hosseinion, 818-507-4617
After reviewing recent filing,picked up a few thousand shares. The company just did a private placement of $1.25 million dollars,10% yield and with convertible feature starting at $0.0125 pps. The fundamental looks good;the shares count is less than 40 million diluted;everything else seems so so. I believe the top line for the current quarter would be a harbinger of the IPA for 2010 and beyond.The wild card: how much impact/difficulty would be effecting its collection/reimbursement by the state of CA which is in a fiscal crisis!
You see, the thing is, it wasnt really trading very much for 20 years so when they did that last reverse split before the RM the said stock price was .0001. But after the RS it was .0136. B/c of the 1 for 136 RS I believe. But it really never traded so those crazy prices stuck.
But before today there was no ask. But as I see now the ask is $4.25 so they are ready to sell shares to investors.
I was hoping for a little FS so to attract some buyers but not sure if they want to do that.
I think I'm a little confused with this whole process. News release at 9am this morning says that they're trading on the OTCBB today. I cant figure out how to buy any, though. And what's the price? Ameritrade says current PPS is $0.0136, And the bid and ask are both way above that. And the 52 week high and lo are both shown as 0.0001. Do i go with the current bid/ask numbers?
New company now AMEH:
Contact Information Business Description
Apollo Medical Holdings, Inc.
1010 N. Central Avenue
Suite 201
Glendale, CA 91202
* Phone: 818-507-4617
*
OTC Market Tier
Pink Quote/OTCBB
*
Primary SIC — Industry Classification
6770 - Blank Checks
*
Business Stage
Shell Company
*
State Of Incorporation
DE
*
Jurisdiction Of Incorporation
United States
*
Company Officers
Warren Hosseinion, CEO, Principal Acct. Officer
*
SEC Reporting Status
SEC Reporting Company
*
CIK
0001083446
*
Fiscal Year End
1/31
*
Estimated Market Cap
1,460 as of Aug 29, 2008
*
Outstanding Shares
14,596,930 as of May 15, 2008
*
Number of Share Holders of Record
303 as of Jun 14, 2008
We will see what happens next Qtr or next 15 yrs.....
10Q Just filed. O/S Changes so cant hope for a reverse merger with a forward split now.
http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=5554960
Common Stock; $.001 Par Value ; 100,000,000 Shares Authorized; 10,175,074 Shares Issued and Outstanding September 30, 2007 and December 31, 2006
Just amazing its been like 20 years and they still have not had a real business.lol That is a long time to go without any operations. Come on now Paul, you guys can come up with something. Maybe 2007 will be their year to solicit and get a reverse merger going. There isnt any or really never was a market for this stock that I am aware of. 1 trade in the past year. Funny with no market makers it shows that SICL is worth .01361 a share. Which if you carry a few decimal points over is equal to the latest reverse split amount.
your right..investers do like these opportunities good chance for big profits....imo..
I just wonder how long it will take them to find a acquisition. This has been around for a long time and laying practically dormant. You would think that they would have found something by now. There are many interested buyers out there for an OTCBB shell. They could make some serious bank by just keeping 10% of the outstanding shares of the merging private company. Instead of sitting around for years paying filing fees. Now the share structure is set. The ball is in there court now. Everyone else is capitalizing on the shell business why shouldnt these guys?
GL
Bid Level #MM's Size Ask Level #MM's Size
0.1000 1 5000 110.0000 1 100
0.0100 1 5000 0.0000 0 0
0.0000 0 0 0.0000 0 0
0.0000 0 0 0.0000 0 0
L2 Quote:
MM on Bid : 2
MM on Ask : 2
MM ID Bid Size Time
HILL 0.1000 5000 07:30:12
NITE 0.0100 5000 07:30:12
MM ID Ask Size Time
HILL 0.0000 -1 07:30:12
NITE 110.0000 100 07:30:12
Siclone Industries, Inc. does not have significant operations. It intends to seek, investigate, and acquire an interest in a business opportunity. The company was founded in 1985. It was formerly known as McKinnely Investments, Inc. and changed its name to Accoline Industries, Inc. in 1986. Further, the name was changed to Siclone Industries, Inc. in 1988. Siclone Industries is based in Layton, Utah.
378 North Main
Suite 124
Layton, UT 84041
United States
Founded in 1985
Phone:
801-497-9075
Fax:
Key Executives
Mr. Paul Adams Siclone Industries Inc. Amends its Articles of Incorporation
07/13/2007
Siclone Industries Inc. announced that the Articles of Incorporation of the Company will be amended to change the name of the Company to a name yet to be chosen by the Board of Directors to better reflect the direction of the Company's business. The Articles of Incorporation of the Company will be amended to increase the authorized shares of common stock, par value $0.001, from 30,000,000 to 100,000,000.
Siclone Industries Inc. announced delayed 10-Q filing
05/15/2007
On 05/15/2007, Siclone Industries Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Siclone Industries Inc. Receives a Going Concern Opinion from Child, Van Wagoner & Bradshaw, PLLC
04/2/2007
Siclone Industries Inc. filed its 10KSB on April 02, 2007 for the period ending December 31, 2006. In this report its auditor, Child, Van Wagoner & Bradshaw, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern
Chief Executive Officer
Age: 47
Compensation as of Fiscal Year 2006.
Followers
|
7
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
127
|
Created
|
08/08/07
|
Type
|
Free
|
Moderators |
AMEH.. - Apollo Medical Industries..APOLLO MEDICAL HOLDINGS, INC.
ApolloMed is a leader in providing hospitals, physician groups and managed care organizations clinical solutions through outsourced hospitalist programs. We are a physician-led group focused on providing, managing, and coordinating the care of hospitalized patients. Over past 10 years we have been able to help our partners improve clinical outcomes, increase patient satisfaction, reduce average length of stay and realize greater efficiencies through the application of best practices and quality management.
ApolloMed currently offers its services at 28 hospitals in the Greater Los Angeles Area. The Company signs exclusive contracts with its partners to staff and manage professional programs for the general care of hospitalized patients. We are able to customize our services to improve patient care and achieve financial and operational benefits for our partners. We tailor each program to meet the needs of our clients and their patients.
To learn more about how ApolloMed can help your organization, please contact us at (818) 396-8050.
BUSINESS SUMMARY |
Apollo Medical Holdings, Inc, together with its subsidiaries, provides management services to medical groups that provide inpatient care services in the United States. The company offers services for hospitals, such as providing care from the emergency room through hospital discharge; admission and care of unassigned and/or uninsured patients; inpatient internal medicine consultation services; emergency room clinical decision unit services; and development of hospital-based physicians programs, including pulmonary, critical care, cardiology, and nephrology. Its services for hospitals also include in-hospital inpatient coverage services; development of evidence-based medicine protocols for common diagnoses; implementation of patient safety guidelines; education of nurses and hospital staff; analysis of statistics via the ApolloWeb, a practice management software program, which allows a physician to enter patient information in real-time; and care of patients at academic medical centers, including the education of medical students, interns, and residents. The company also offers services for health carriers and medical groups, which comprise admission and care of assigned patients; communication with primary care physicians upon admission, during the patient?s hospital stay, and upon discharge; transfer of out-of-network patients back to designated hospitals; and communication with case managers, social workers, and medical group personnel, as well as hospital-based physician consulting services. Apollo Medical Holdings, Inc is headquartered in Glendale, California. |
October 31, 2010 | January 31, 2010 | |||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash and cash equivalents | $ | 501,639 | $ | 665,737 | ||||
Accounts receivable, net | 643,107 | 457,517 | ||||||
Receivable from officers | 8,616 | 23,483 | ||||||
Due from affiliate | 3,900 | 2,850 | ||||||
Prepaid expenses | 46,235 | 30,165 | ||||||
Total current assets | 1,203,497 | 1,179,752 | ||||||
Deferred commission cost, net | 85,938 | 114,063 | ||||||
Property and equipment, net | 7,865 | 11,627 | ||||||
TOTAL ASSETS | $ | 1,297,300 | $ | 1,305,442 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||
CURRENT LIABILITIES: | ||||||||
Accounts payable and accrued liabilities | $ | 150,116 | $ | 104,252 | ||||
Total current liabilities | 150,116 | 104,252 | ||||||
Convertible notes, net | 1,248,186 | 1,247,582 | ||||||
Total liabilities | 1,398,302 | 1,351,834 | ||||||
STOCKHOLDERS' DEFICIT: | ||||||||
Preferred stock, par value $0.001 ; | ||||||||
5,000,000 shares authorized; none issued | - | - | ||||||
Common Stock, par value $0.001; 100,000,000 shares authorized, | ||||||||
27,635,774 and 27,041,328 shares issued and outstanding | ||||||||
as of October 31, 2010 and January 31, 2010 | 27,636 | 27,041 | ||||||
Additional paid-in-capital | 986,266 | 939,483 | ||||||
Accumulated deficit | (1,343,019 | ) | (1,241,031 | ) | ||||
Total | (329,117 | ) | (274,507 | ) | ||||
Non-controlling interest | 228,115 | 228,115 | ||||||
Total stockholders' deficit | (101,002 | ) | (46,392 | ) | ||||
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ | 1,297,300 | $ | 1,305,442 |
For the Three Month Periods Ended | For the Nine Month Periods Ended | |||||||||||||||
October 31, | October 31, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
NET REVENUE | $ | 1,019,078 | $ | 616,975 | $ | 2,861,658 | $ | 1,699,100 | ||||||||
COST OF REVENUE | 868,119 | 455,183 | 2,407,524 | 1,262,430 | ||||||||||||
GROSS PROFIT | 150,959 | 161,792 | 454,134 | 436,670 | ||||||||||||
Operating expenses: | ||||||||||||||||
General and administrative | 152,013 | 139,557 | 427,720 | 434,225 | ||||||||||||
Depreciation | 2,330 | 9,622 | 8,330 | 30,297 | ||||||||||||
Total operating expenses | 154,343 | 149,179 | 436,050 | 464,522 | ||||||||||||
INCOME/(LOSS) FROM OPERATIONS | (3,384 | ) | 12,613 | 18,084 | (27,852 | ) | ||||||||||
OTHER INCOME/(EXPENSES): | ||||||||||||||||
Interest expense | (31,748 | ) | (15,738 | ) | (94,736 | ) | (25,546 | ) | ||||||||
Financing cost | (9,375 | ) | (25,000 | ) | (28,125 | ) | (25,000 | ) | ||||||||
Other income | 4,292 | - | 4,389 | - | ||||||||||||
Total other expenses | (36,831 | ) | (40,738 | ) | (118,472 | ) | (50,546 | ) | ||||||||
LOSS BEFORE INCOME TAXES | (40,215 | ) | (28,125 | ) | (100,388 | ) | (78,398 | ) | ||||||||
Provision for Income Tax | 800 | 800 | 1,600 | 1,600 | ||||||||||||
NET LOSS | $ | (41,015 | ) | $ | (28,925 | ) | $ | (101,988 | ) | $ | (79,998 | ) | ||||
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING, | ||||||||||||||||
BASIC AND DILUTED | 27,635,774 | 26,805,493 | 27,370,367 | 26,260,574 | ||||||||||||
*BASIC AND DILUTED NET LOSS PER SHARE | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) |
As of July 31, 2010 | As of January 31, 2010 | |||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash and cash equivalents | $ | 534,332 | $ | 665,737 | ||||
Accounts receivable, net | 622,734 | 457,517 | ||||||
Receivable from officers | 23,664 | 23,483 | ||||||
Due from affiliate | 3,650 | 2,850 | ||||||
Prepaid expenses | 12,567 | 30,165 | ||||||
Total current assets | 1,196,947 | 1,179,752 | ||||||
Prepaid commssion cost | 95,312 | 114,063 | ||||||
Property and equipment - net | 10,196 | 11,627 | ||||||
TOTAL ASSETS | $ | 1,302,455 | $ | 1,305,442 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIT: | ||||||||
CURRENT LIABILITIES: | ||||||||
Accounts payable and accrued liabilities | $ | 114,457 | $ | 104,252 | ||||
Total current liabilities | 114,457 | 104,252 | ||||||
Convertible notes, net | 1,247,985 | 1,247,582 | ||||||
Total liabilities | 1,362,442 | 1,351,834 | ||||||
STOCKHOLDERS' DEFICIT: | ||||||||
Preferred stock, par value $0.001 ; | ||||||||
5,000,000 shares authorized; none issued | - | - | ||||||
Common Stock, par value $0.001; 100,000,000 shares authorized, | ||||||||
27,635,774 and 27,041,328 shares issued and outstanding | ||||||||
as on July 31, 2010 and January 31, 2010 | 27,636 | 27,041 | ||||||
Additional paid-in-capital | 986,266 | 939,483 | ||||||
Accumulated deficit | (1,302,004 | ) | (1,241,031 | ) | ||||
Total | (288,102 | ) | (274,507 | ) | ||||
Non-controlling interest | 228,115 | 228,115 | ||||||
Total stockholders' deficit | (59,987 | ) | (46,392 | ) | ||||
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ | 1,302,455 | $ | 1,305,442 |
For the Three Months ended | For the Six Months ended | |||||||||||||||
July 31, | July 31, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
REVENUES | $ | 1,039,695 | $ | 580,942 | $ | 1,842,580 | $ | 1,082,125 | ||||||||
COST OF SERVICES | 864,719 | 387,692 | 1,539,405 | 807,247 | ||||||||||||
GROSS REVENUE | 174,976 | 193,250 | 303,175 | 274,878 | ||||||||||||
Operating expenses: | ||||||||||||||||
General and administrative | 190,516 | 122,105 | 275,708 | 294,668 | ||||||||||||
Depreciation | 2,993 | 10,338 | 5,999 | 20,675 | ||||||||||||
Total operating expenses | 193,509 | 132,443 | 281,707 | 315,343 | ||||||||||||
PROFIT/(LOSS) FROM OPERATIONS | (18,533 | ) | 60,807 | 21,468 | (40,465 | ) | ||||||||||
OTHER EXPENSES: | ||||||||||||||||
Interest expense | 31,465 | 4,958 | 62,988 | 9,807 | ||||||||||||
Financing cost | 9,375 | - | 18,750 | - | ||||||||||||
Other expense | 757 | - | (97 | ) | - | |||||||||||
Total other expenses | 41,597 | 4,958 | 81,641 | 9,807 | ||||||||||||
INCOME/(LOSS) BEFORE INCOME TAXES | (60,130 | ) | 55,849 | (60,173 | ) | (50,272 | ) | |||||||||
Provision for income tax | - | - | 800 | 800 | ||||||||||||
NET INCOME/(LOSS) | $ | (60,130 | ) | $ | 55,849 | $ | (60,973 | ) | $ | (51,072 | ) | |||||
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING, BASIC AND DILUTED | 27,452,197 | 26,096,306 | 27,342,771 | 25,985,136 | ||||||||||||
*BASIC AND DILUTED NET INCOME/(LOSS) PER SHARE | $ | (0.00 | ) | $ | 0.00 | $ | (0.00 | ) | $ | (0.00 | ) |
As of April 30, 2010 | As of January 31, 2010 | |||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash and cash equivalents | $ | 504,540 | $ | 665,737 | ||||
Accounts receivable, net | 653,672 | 457,517 | ||||||
Receivable from officers | 23,483 | 23,483 | ||||||
Due from affiliate | 3,650 | 2,850 | ||||||
Prepaid expenses | 22,821 | 30,165 | ||||||
Total current assets | 1,208,166 | 1,179,751 | ||||||
Deferred commission cost | 104,687 | 114,063 | ||||||
Property and equipment - net | 13,189 | 11,627 | ||||||
TOTAL ASSETS | $ | 1,326,042 | $ | 1,305,441 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIT: | ||||||||
CURRENT LIABILITIES: | ||||||||
Accounts payable and accrued liabilities | $ | 95,426 | $ | 104,252 | ||||
Total current liabilities | 95,426 | 104,252 | ||||||
Convertible notes, net | 1,247,784 | 1,247,582 | ||||||
Total liabilities | 1,343,210 | 1,351,834 | ||||||
STOCKHOLDERS' DEFICIT: | ||||||||
Preferred stock, par value $0.001 ; 5,000,000 shares authorized; none issued | - | - | ||||||
Common Stock, par value $0.001; 100,000,000 shares authorized, 27,424,661 and 27,041,328 shares issued and outstanding as on April 30, 2010 and January 31, 2010 | 27,424 | 27,041 | ||||||
Additional paid-in-capital | 969,166 | 939,483 | ||||||
Accumulated deficit | (1,241,873 | ) | (1,241,031 | ) | ||||
Total | (245,283 | ) | (274,508 | ) | ||||
Non-controlling interest | 228,115 | 228,115 | ||||||
Total stockholders' deficit | (17,168 | ) | (46,393 | ) | ||||
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ | 1,326,042 | $ | 1,305,441 |
For the three month periods ended April 30, | ||||||||
2010 | 2009 | |||||||
REVENUES | $ | 802,885 | $ | 501,183 | ||||
COST OF SERVICES | 674,686 | 419,554 | ||||||
GROSS REVENUE | 128,199 | 81,629 | ||||||
Operating expenses: | ||||||||
General and administrative | 85,192 | 172,562 | ||||||
Depreciation | 3,006 | 10,338 | ||||||
Total operating expenses | 88,198 | 182,900 | ||||||
PROFIT/(LOSS) FROM OPERATIONS | 40,001 | (101,272 | ) | |||||
OTHER EXPENSES: | ||||||||
Interest expense | 31,523 | 4,849 | ||||||
Financing cost | 9,375 | - | ||||||
Other expense | (854 | ) | - | |||||
Total other expenses | 40,044 | 4,849 | ||||||
LOSS BEFORE INCOME TAXES | (43 | ) | (106,121 | ) | ||||
Provision for income tax | 800 | 800 | ||||||
NET LOSS | $ | (843 | ) | $ | (106,921 | ) | ||
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING, | ||||||||
BASIC AND DILUTED | 27,229,655 | 25,870,220 | ||||||
*BASIC AND DILUTED NET LOSS PER SHARE | $ | (0.00 | ) | $ | (0.00 | ) |
For the Three months ended | For the Nine months ended | |||||||||||||||
October 31, | October 31, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
REVENUES | $ | 616,975 | 479,808 | $ | 1,699,100 | 499,603 | ||||||||||
Operating expenses: | ||||||||||||||||
Cost of services - physician practice salaries, benefits and other | 455,183 | 488,605 | 1,262,430 | 531,411 | ||||||||||||
General and administrative | 139,557 | 278,854 | 434,225 | 681,233 | ||||||||||||
Depreciation | 9,622 | 9,996 | 30,297 | 9,996 | ||||||||||||
Total operating expenses | 604,362 | 777,455 | 1,726,952 | 1,222,640 | ||||||||||||
INCOME (LOSS) FROM OPERATIONS | 12,613 | (297,647 | ) | (27,852 | ) | (723,037 | ) | |||||||||
OTHER EXPENSES: | ||||||||||||||||
Interest expense | 15,738 | 5,356 | 25,546 | 5,356 | ||||||||||||
Financing cost | 25,000 | 23,500 | 25,000 | 23,500 | ||||||||||||
Total other expenses | 40,738 | 28,856 | 50,546 | 28,856 | ||||||||||||
NET LOSS BEFORE INCOME TAXES | (28,125 | ) | (326,503 | ) | (78,398 | ) | (751,893 | ) | ||||||||
Provision for income tax | 800 | - | 1,600 | 800 | ||||||||||||
NET LOSS | (28,925 | ) | (326,503 | ) | (79,998 | ) | (752,693 | ) | ||||||||
Net (income) loss attributable to noncontrolling interest | 53,161 | (41,712 | ) | 106,087 | (41,712 | ) | ||||||||||
Net loss attributable to Apollo Medical Holdings, Inc. | $ | (82,086 | ) | $ | (284,791 | ) | $ | (186,084 | ) | $ | (710,981 | ) | ||||
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING, | ||||||||||||||||
BASIC AND DILUTED | 26,805,493 | 25,734,174 | 26,260,574 | 20,063,728 | ||||||||||||
*BASIC AND DILUTED NET LOSS PER SHARE | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.00 | ) | $ | (0.04 | ) |
Nine months ended October 31, | ||||||||
2009 | 2008 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Adjustments to reconcile net loss to net cash | ||||||||
(used in) operating activities: | ||||||||
Net loss | $ | (79,998 | ) | $ | (752,693 | ) | ||
Depreciation | 30,298 | 9,996 | ||||||
Bad debt expense | 4,954 | 23,514 | ||||||
Issuance of shares for service | 101,455 | 72,545 | ||||||
Warrant Discount | 9,642 | - | ||||||
Shares issued as finance charge | - | 13,500 | ||||||
Shares issued for consulting expense | - | 67,500 | ||||||
Exercise of notes payable conversion | - | 170,375 | ||||||
Minority Interest | - | 161,512 | ||||||
(Increase) decrease in current assets: | ||||||||
Accounts receivable | (165,874 | ) | (174,457 | ) | ||||
Prepaid expenses | (10,822 | ) | (9,614 | ) | ||||
Prepaid Commission | (123,438 | ) | - | |||||
Due from related party | (800 | ) | (29,897 | ) | ||||
Increase (decrease) in current liabilities: | - | - | ||||||
Accounts payable and accrued liabilities | 46,458 | 17,975 | ||||||
Net cash used in operating activities | (188,126 | ) | (429,743 | ) | ||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Property and Equipment | - | (69,510 | ) | |||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Process from/(Payment to) notes payables | ||||||||
Process from/(Payment to) notes payables- related parties | (75,000 | ) | 70,000 | |||||
Process from/(Payment to) notes convertibles | 1,240,358 | |||||||
Process from/(Payment to) line of credit | (198,000 | ) | 198,000 | |||||
Proceeds from issuance of common stock for cash | - | 335,000 | ||||||
Net cash provided by financing activities | 967,358 | 603,000 | ||||||
NET INCREASE IN CASH & CASH EQUIVALENTS | 779,233 | 103,747 | ||||||
CASH & CASH EQUIVALENTS, BEGINNING BALANCE | 84,161 | 44,352 | ||||||
CASH & CASH EQUIVALENTS, ENDING BALANCE | $ | 863,394 | $ | 148,099 | ||||
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION | ||||||||
Interest paid during the year | $ | 13,153 | $ | 3,452 | ||||
Taxes paid during the year | $ | 1,600 | $ | - | ||||
Conversion of notes payable to Equity | $ | 200,000 | $ | - |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |